Mesoblast and BMT CTN to initiate pivotal trial of Ryoncil as part of first─line regimen in adults with severe acute GvHD refractory to steroids

Media coverage

• Title	Mesoblast and BMT CTN to initiate pivotal trial of Ryoncil as part of first─line regimen in adults with severe acute GvHD refractory to steroids
  Media name/outlet	PharmaBiz
  Country/Territory	India
  Date	22/11/25
  URL	ct.moreover.com/?a=58237511105&p=1gw&v=1&x=QOtoJ3qrKic442ZoYwLaFQ
  Persons	John Levine

• Title	Mesoblast and BMT CTN to initiate pivotal trial of Ryoncil as part of first-line regimen in adults with severe acute GvHD refractory to steroids
  Media name/outlet	PharmaBiz
  Country/Territory	India
  Date	22/11/25
  Persons	John Levine